Literature DB >> 10562589

Serum interleukin 10 and interleukin 11 in patients with acute pancreatitis.

C C Chen1, S S Wang, R H Lu, F Y Chang, S D Lee.   

Abstract

BACKGROUND: Proinflammatory and anti-inflammatory cytokines are involved in the pathogenesis of acute pancreatitis. AIMS: To measure the serial serum levels of interleukin 10 and interleukin 11 in patients with acute pancreatitis and analyse the relation of these anti-inflammatory cytokines to disease severity.
METHODS: In 50 patients with acute pancreatitis, the serum concentrations of interleukin 10 and interleukin 11 were determined on days one, two, three, four, and seven after admission. Serum C reactive protein levels were evaluated on days one and two. Severity of pancreatitis was determined according to the Atlanta criteria.
RESULTS: Serum concentrations of interleukin 10 on days one to seven were significantly higher in patients with severe pancreatitis than in those with mild pancreatitis. Patients with severe attacks had significantly elevated serum interleukin 11 concentrations on days two to four compared with those with mild attacks, but not on days one and seven. With cut off levels of 30 pg/ml for interleukin 10, 10.5 pg/ml for interleukin 11, and 115 mg/l for C reactive protein, the accuracy rates for detecting severe pancreatitis were 84%, 64%, and 78% respectively on day one and 82%, 74%, and 84% respectively on day two.
CONCLUSIONS: Serum interleukin 10 and interleukin 11 concentrations reflect the severity of acute pancreatitis. Interleukin 10 is a useful variable for early prediction of the prognosis of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10562589      PMCID: PMC1727757          DOI: 10.1136/gut.45.6.895

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  34 in total

1.  Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis.

Authors:  A R Exley; T Leese; M P Holliday; R A Swann; J Cohen
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

2.  Interleukin-8 and neutrophil activation in acute pancreatitis.

Authors:  V Gross; R Andreesen; H G Leser; M Ceska; E Liehl; M Lausen; E H Farthmann; J Schölmerich
Journal:  Eur J Clin Invest       Date:  1992-03       Impact factor: 4.686

Review 3.  Cytokines, sepsis and immunomodulation.

Authors:  R G Molloy; J A Mannick; M L Rodrick
Journal:  Br J Surg       Date:  1993-03       Impact factor: 6.939

4.  Diagnostic relevance of interleukin pattern, acute-phase proteins, and procalcitonin in early phase of post-ERCP pancreatitis.

Authors:  M Oezcueruemez-Porsch; D Kunz; P D Hardt; T Fadgyas; O Kress; H U Schulz; H Schnell-Kretschmer; H Temme; S Westphal; C Luley; H U Kloer
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 5.  A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992.

Authors:  E L Bradley
Journal:  Arch Surg       Date:  1993-05

Review 6.  The biology of interleukin 11.

Authors:  S Neben; K Turner
Journal:  Stem Cells       Date:  1993-07       Impact factor: 6.277

Review 7.  Inflammatory mediators and cytokines--new aspects of the pathophysiology and assessment of severity of acute pancreatitis?

Authors:  V Gross; H G Leser; A Heinisch; J Schölmerich
Journal:  Hepatogastroenterology       Date:  1993-12

8.  Role of interleukin-6 in acute pancreatitis. Comparison with C-reactive protein and phospholipase A.

Authors:  J A Viedma; M Pérez-Mateo; J E Domínguez; F Carballo
Journal:  Gut       Date:  1992-09       Impact factor: 23.059

9.  Role of interleukin-6 in mediating the acute phase protein response and potential as an early means of severity assessment in acute pancreatitis.

Authors:  D I Heath; A Cruickshank; M Gudgeon; A Jehanli; A Shenkin; C W Imrie
Journal:  Gut       Date:  1993-01       Impact factor: 23.059

10.  Interleukin-10 production during septicaemia.

Authors:  A Marchant; J Devière; B Byl; D De Groote; J L Vincent; M Goldman
Journal:  Lancet       Date:  1994-03-19       Impact factor: 79.321

View more
  18 in total

1.  Different profile of cytokine synthesis according to the severity of acute pancreatitis.

Authors:  Raquel Laveda; Juan Martinez; Carlos Munoz; Juan-Carlos Penalva; Jesus Saez; German Belda; Salvador Navarro; Faust Feu; Anton Mas; Jose-Ma Palazon; Jose Sanchez-Paya; Jose Such; Miguel Perez-Mateo
Journal:  World J Gastroenterol       Date:  2005-09-14       Impact factor: 5.742

2.  Degradation and inactivation of plasma tumor necrosis factor-alpha by pancreatic proteases in experimental acute pancreatitis.

Authors:  G Alsfasser; B Antoniu; S P Thayer; A L Warshaw; C Fernández-del Castillo
Journal:  Pancreatology       Date:  2005-03-15       Impact factor: 3.996

Review 3.  Immune-modulating therapy in acute pancreatitis: fact or fiction.

Authors:  Karolina Akinosoglou; Charalambos Gogos
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications.

Authors:  J Mayer; B Rau; F Gansauge; H G Beger
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 5.  Inflammation and immunosuppression in severe acute pancreatitis.

Authors:  Marja-Leena Kylänpää; Heikki Repo; Pauli Antero Puolakkainen
Journal:  World J Gastroenterol       Date:  2010-06-21       Impact factor: 5.742

6.  Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock.

Authors:  Dian-Liang Zhang; Hong-Mei Zheng; Bao-Jun Yu; Zhi-Wei Jiang; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

7.  A novel autoimmune pancreatitis model in MRL mice treated with polyinosinic:polycytidylic acid.

Authors:  W-M Qu; T Miyazaki; M Terada; K Okada; S Mori; H Kanno; M Nose
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

8.  Cost-effectiveness analysis of early veno-venous hemofiltration for severe acute pancreatitis in China.

Authors:  Kun Jiang; Xin-Zu Chen; Qing Xia; Wen-Fu Tang; Lei Wang
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

9.  Time frames for analysis of inflammatory mediators in acute pancreatitis: improving admission triage.

Authors:  Andrés Duarte-Rojo; Jorge Suazo-Barahona; María Teresa Ramírez-Iglesias; Luis F Uscanga; Guillermo Robles-Díaz
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

10.  Association between serum interleukin-35 levels and severity of acute pancreatitis.

Authors:  Yi-Li Zhang; Xiu-Yun Zhou; Xian-Yang Guo; Jun-Wei Tu
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.